PROGEN closed today lower at kr0.11, a decrease of -7.4236% from yesterday's close, completing a monthly decrease of -85.9788% or -kr0.65. Over the past 12 months, PROGEN stock lost -65.9164%.
PROGEN is not paying dividends to its shareholders.
The last earnings report, released on May 31, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Prostatype Genomics AB has completed 1 stock splits, with the recent split occurring on Oct 31, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).